Does AOD-9604 need to be refrigerated? Storage guide

Last updated 2026-07-25

Does AOD-9604 need to be refrigerated before it's mixed?

Lyophilized (freeze-dried) AOD-9604 is the powder form that comes in a sealed vial before you add any liquid. Peptides in this state are chemically more stable than reconstituted solutions because there's no water present to drive degradation reactions like hydrolysis or aggregation. That said, "stable" doesn't mean indestructible. Most peptide manufacturers and compounding pharmacies recommend keeping unreconstituted vials refrigerated at 2-8°C (36-46°F) for the longest shelf life, and freezing at -20°C for extended storage of many months. Room temperature exposure for short windows, a few days during shipping, generally doesn't ruin the peptide, which is why most vials arrive in insulated packaging rather than dry ice. The honest caveat here is that AOD-9604 itself has not been through the kind of rigorous, published stability testing that an FDA-approved drug undergoes. The clinical literature on AOD-9604 focuses on its metabolic effects and detection in doping labs ^[1][2], not shelf-life data under different temperature conditions. So storage guidance for this peptide comes from general peptide chemistry and compounding pharmacy practice, not a study specific to AOD-9604's degradation curve. If you're sourcing through a provider-reviewed channel, check the pharmacy's own handling instructions on the certificate of analysis or product insert, since practices vary slightly by manufacturer and buffer formulation.

Does reconstituted AOD-9604 need to be kept in the fridge?

Yes. Once you reconstitute AOD-9604 with bacteriostatic water, it needs to go straight into the refrigerator at 2-8°C (36-46°F). This is not optional if you want the peptide to remain intact and free of microbial growth. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which slows bacterial growth in a multi-use vial but doesn't stop peptide degradation. Once liquid is introduced, the peptide bonds are exposed to hydrolysis, and any temperature swings accelerate that breakdown. A vial left on a counter or in a warm car for hours is a different product than one that's been refrigerated the whole time, even if it looks the same. Most peptide vendors and compounding guidance put reconstituted shelf life at roughly 2 to 3 weeks under refrigeration. Some formulations may hold longer, but there's no universal number backed by AOD-9604-specific stability trials, so treat 2-3 weeks as a practical ceiling rather than a guarantee. If you're unsure how your specific vial was mixed or with what diluent, the reconstitution steps here walk through the process and the storage implications of each choice.

Can AOD-9604 be left out at room temperature?

Briefly, yes, for the lyophilized powder. For the reconstituted liquid, no, not if you want it to stay effective and safe to inject. Unreconstituted vials can typically handle a day or two at room temperature without meaningful harm, which is why shipping without cold packs is common practice across the peptide industry. But once mixed, leaving a vial out overnight or in a warm room for extended periods raises two separate problems: faster chemical degradation of the peptide itself, and a higher risk of bacterial growth despite the bacteriostatic water's preservative. There isn't a published AOD-9604 stability study that gives you an exact hour-by-hour degradation curve at room temperature. In the absence of that data, the conservative and standard practice in compounding pharmacy is simple: mix it, refrigerate it, and don't let it sit out longer than the time it takes to draw your dose.

Should AOD-9604 be frozen for long-term storage?

Freezing works for lyophilized powder if you're storing it for months before use, but it is not a routine strategy for reconstituted liquid. Many peptide manufacturers state that unreconstituted powder can be kept at -20°C for extended periods, sometimes cited as up to a year or more, though again this comes from general peptide storage practice rather than an AOD-9604-specific trial. If you've bought more vials than you'll use in the next month or two, freezing the unmixed powder is a reasonable way to protect your investment. Once reconstituted, though, freeze-thaw cycles are hard on peptide structure. Repeated freezing and thawing can cause the peptide to aggregate or lose potency, and there's a practical problem too: you can't easily draw an accurate dose from a frozen vial. Refrigeration, not freezing, is the standard for any peptide solution you plan to use within a few weeks.

How long does AOD-9604 last once mixed, and how do you know it's gone bad?

Refrigerated reconstituted AOD-9604 is generally considered usable for about 2-3 weeks, though this is a practical estimate from compounding and peptide-industry norms rather than a fixed number from clinical trials. Signs a vial may have degraded include visible cloudiness, discoloration, or particulate matter floating in the solution. Peptide solutions should be clear. If yours isn't, don't inject it, even if you're inside the expected window. A subtler sign is a change in how the peptide seems to feel or perform, though this is inherently unreliable since AOD-9604's actual physiological effects in humans are themselves not well established by controlled trial data ^[3]. That's an important caveat before you start interpreting "it doesn't feel like it's working anymore" as a storage problem. Given the weak evidence base for the compound's effects in the first place, subjective changes in perceived effect aren't a reliable proxy for peptide integrity.

Does AOD-9604 actually work for fat loss, and why does storage even matter if the data is weak?

This is the part that shouldn't get buried under storage tips. AOD-9604 is a fragment of human growth hormone, specifically the region of the hGH molecule (roughly amino acids 176-191) that researchers identified as responsible for HGH's fat-metabolizing effects without triggering the growth-promoting or blood-sugar effects of full-length HGH. The rationale made sense on paper: isolate the piece of the molecule that burns fat, drop the rest. A 2004 review in Current Opinion in Investigational Drugs summarized AOD-9604 as a metabolic fragment developed on this basis ^[1]. But the honest summary of the human trial record is that AOD-9604 went through obesity clinical trials and did not produce weight-loss results that separated convincingly from placebo. A 2006 review of obesity drugs in clinical development covers AOD-9604 among other candidates being tested at the time, situating it within a broader pipeline where most fragment and peptide approaches failed to show a clear advantage over placebo in controlled human trials ^[4]. Separately, industry-facing overviews of the clinical trial landscape from the mid-2000s ("Gateways to clinical trials," 2003 and 2005) tracked AOD-9604 as it moved through development ^[5][6][7], but no FDA approval followed, and it does not appear in the FDA's Drugs@FDA database of approved products [reference the FDA database directly] ^[8]. So why does storage matter for a compound with a weak efficacy record? Because people are still buying and injecting it, largely through research-chemical and compounding channels, and if you're going to use it anyway, using a properly stored, intact peptide is at minimum safer and more honest about what you're actually injecting than a degraded, possibly contaminated vial. Storage quality doesn't fix a weak evidence base. It just means you're not adding a second, avoidable problem on top of the first. If you want the full trial history and why the weight-loss signal never separated from placebo, our evidence page on the peptide covers it in more detail.

Is AOD-9604 legal, and how is it typically obtained?

AOD-9604 is not FDA-approved for any use in humans, and it doesn't appear in the FDA's Drugs@FDA database of approved drug products ^[8]. It is also not on FDA's current list of bulk drug substances that can be used in 503A pharmacy compounding ^[9] or the 503B outsourcing facility bulks list ^[10], which are the lists that determine whether a compounding pharmacy can legally use a substance as an active ingredient in a compounded prescription drug under 21 U.S.C. 353a ^[11]. In practice, most AOD-9604 sold in the US moves through "research use only" channels, explicitly not labeled or marketed for human use, injection, or consumption. Under FDA's intended use regulation at 21 CFR 201.128, how a product is labeled and marketed, more than its chemical identity, factors into whether it's regulated as a drug ^[12]. This is why legitimate sellers stick to research-only language rather than making dosing or health claims. If your interest is a provider-reviewed route rather than an unregulated research-chemical purchase, that changes what oversight looks like at the point of sale, even though the underlying substance's FDA approval status doesn't change. Comparing where to buy AOD-9604 is worth reading before you pick a vendor, and if cost and vendor comparisons are your main question, see the pricing landscape here.

Does storage or handling affect AOD-9604 showing up on a drug test?

This is a less obvious storage-adjacent question, but it comes up: does how AOD-9604 was stored or handled change whether it's detectable in doping control? The answer is no, storage doesn't change its detectability profile, but the compound's detection story itself is worth knowing. A 2013 study in Drug Testing and Analysis found that AOD-9604 does not influence the WADA hGH isoform immunoassay, meaning it won't trigger a positive result on the standard growth hormone isoform test used in anti-doping ^[13]. That doesn't mean it's untestable, though. Analytical chemistry reviews describe dedicated mass spectrometry methods developed specifically to detect small peptides like AOD-9604 in urine, including approaches using liquid chromatography and ion mobility mass spectrometry for peptides under 2 kDa ^[9][14], and broader reviews of emerging non-approved drugs in doping control ^[15] and peptide detection strategy ^[16] confirm that anti-doping labs have built targeted assays for fragment peptides like this one, separate from the standard HGH test. AOD-9604 is banned by WADA as a growth hormone releasing peptide/fragment, regardless of whether it flags the isoform test. Storage temperature has no bearing on any of this; it's purely a detection chemistry question, not a handling question.

What's the safest, most practical way to store AOD-9604 at home?

Keep it simple and consistent. Store unreconstituted vials in the refrigerator door or a stable fridge shelf at 2-8°C, away from light. Once you mix a vial with bacteriostatic water, label it with the date and keep it refrigerated continuously, only pulling it out briefly to draw your dose. Don't leave reconstituted vials in a gym bag, car, or on a counter between uses. Don't refreeze a vial that's already been reconstituted and refrigerated. Don't use a vial past roughly 3 weeks post-reconstitution, and don't use one that looks cloudy or has visible particles regardless of how long it's been. A cheap fridge thermometer removes the guesswork; home refrigerators can run colder or warmer than their dial suggests, and consistent 2-8°C matters more than any single storage tip on this page.

How does AOD-9604's practical use compare to better-studied alternatives?

If storage logistics and a thin efficacy record both give you pause, it's worth knowing what else is out there with a stronger human data trail. Tesamorelin, for instance, is FDA-approved (for HIV-associated lipodystrophy) and has actual controlled trial data behind its fat-reduction claims, which is a fundamentally different evidence tier than AOD-9604's unproven-in-humans obesity trial record.

For a full side-by-side on mechanism, evidence, and what each is actually approved or studied for, see the AOD-9604 vs tesamorelin comparison.

Where does a provider-reviewed source fit into the storage picture?

Storage quality only matters if what you started with was legitimate to begin with. A provider-reviewed sourcing route, where a pharmacy partner handles compounding and fulfillment under pharmacy oversight rather than an unregulated research-chemical seller, gives you more confidence that the vial you received was made and shipped under real quality control before it ever reaches your fridge. AOD-9604 Co reviews providers along these lines and points readers toward routes where a licensed pharmacy is actually fulfilling the product, rather than a generic research-chemical listing with no accountability behind it. That doesn't change the underlying trial record; it changes whether the vial in your hand matches its label and was handled correctly before it got to you. If you're at the stage of actually placing an order, read the sourcing comparison first so you know what to check on a certificate of analysis and what storage instructions should already be printed on the product insert.

Frequently asked questions

How long can AOD-9604 sit out of the fridge before it goes bad?

Lyophilized (unmixed) powder can typically handle a day or two at room temperature without major harm, which is why it's often shipped without cold packs. Reconstituted liquid is different: it should go into the fridge immediately after mixing and shouldn't sit out beyond the time it takes to draw a dose.

What temperature should AOD-9604 be stored at?

Standard peptide storage guidance is 2-8°C (36-46°F) for both unreconstituted and reconstituted AOD-9604, matching typical home refrigerator temperatures. Unmixed powder can also be frozen at -20°C for longer-term storage, but reconstituted solution should not be frozen.

Can you freeze AOD-9604 after mixing it?

It's not recommended. Freeze-thaw cycles can degrade peptide structure and cause aggregation, and a frozen vial makes accurate dosing difficult. Freezing is only standard practice for unreconstituted lyophilized powder intended for long-term storage, not for solution you plan to use within weeks.

How long does reconstituted AOD-9604 last?

Practical guidance from peptide-industry and compounding norms puts reconstituted AOD-9604's usable shelf life at about 2-3 weeks under continuous refrigeration at 2-8°C. There's no AOD-9604-specific published stability trial establishing an exact figure, so treat this as a conservative estimate rather than a guarantee.

Does AOD-9604 actually work for weight loss?

The human trial record is weak. AOD-9604 went through obesity clinical trials, and the weight-loss results did not separate convincingly from placebo, despite the fragment's plausible mechanism ^[1][4]. It is not FDA-approved for weight loss or any other indication ^[8].

Is AOD-9604 legal to buy in the US?

AOD-9604 is not FDA-approved and does not appear on FDA's 503A or 503B bulk drug substance lists for compounding ^[9][10]. Most legal sales occur through research-use-only channels that don't market it for human use, consistent with FDA's intended-use framework at 21 CFR 201.128 ^[12].

Will improper storage make AOD-9604 dangerous rather than just ineffective?

A degraded peptide is more likely to simply lose potency than become acutely toxic, but a vial that's grown bacterial contamination from improper handling (left unrefrigerated, contaminated draws) is a real infection risk. Cloudy or discolored solution should never be injected regardless of the reason.

Does AOD-9604 show up on a WADA drug test?

AOD-9604 does not trigger the standard WADA hGH isoform immunoassay ^[13], but dedicated mass spectrometry methods exist specifically to detect small peptides like it in urine ^[9][14]. It remains a banned substance in sport regardless of which test method is used.

What's the difference between lyophilized and reconstituted AOD-9604 for storage purposes?

Lyophilized (freeze-dried) powder is chemically stable and can handle brief room-temperature exposure or long-term freezing. Reconstituted (mixed with bacteriostatic water) solution is far less stable, needs continuous refrigeration at 2-8°C, and has a shelf life measured in weeks, not months.

How do I know if my AOD-9604 vial has degraded?

Visible cloudiness, discoloration, or floating particles are the clearest signs of a bad vial and mean you shouldn't inject it. Because AOD-9604's actual physiological effects in humans are poorly established by controlled trials ^[3], changes in how it seems to be "working" are not a reliable indicator of degradation.

Should I buy AOD-9604 from a research-chemical site or a compounding pharmacy?

A provider-reviewed route through a licensed pharmacy partner gives more accountability over how the product was made, stored, and shipped before it reaches you, compared to an unregulated research-chemical listing. Neither route changes AOD-9604's weak human obesity trial record or its lack of FDA approval ^[8].

Can I store AOD-9604 in the refrigerator door?

Yes, as long as the door consistently holds 2-8°C; a cheap fridge thermometer is worth using since refrigerator doors can run warmer than interior shelves. Avoid storing vials near the door seal if your fridge is opened frequently, since temperature swings there are more common.

Sources

1. PubMed, Current Opinion in Investigational Drugs (2004), PMID 15134286: AOD-9604 is characterized as a metabolic hGH fragment reviewed for its investigational obesity development
2. PubMed, Journal of the American Academy of Orthopaedic Surgeons Global Research & Reviews (2026), PMID 41490200: Review of therapeutic peptides in orthopaedics covering applications and challenges relevant to peptides like AOD-9604
3. PubMed, Sports Medicine (2026), PMID 41966639: Review of safety and efficacy data for approved and unapproved peptide therapies used for musculoskeletal injury and athletic performance
4. PubMed, Current Opinion in Investigational Drugs (2006), PMID 16625817: Review of obesity drugs in clinical development in the mid-2000s, including fragment peptide candidates
5. PubMed, Methods and Findings in Experimental and Clinical Pharmacology (2003), PMID 14685303: Industry clinical trial pipeline tracking report referencing AOD-9604's development status
6. PubMed, Methods and Findings in Experimental and Clinical Pharmacology (2003), PMID 14571286: Industry clinical trial pipeline tracking report referencing AOD-9604's development status
7. PubMed, Methods and Findings in Experimental and Clinical Pharmacology (2005), PMID 15834452: Later clinical trial pipeline tracking report following AOD-9604 through further development
8. FDA, Drugs@FDA database: AOD-9604 does not appear as an FDA-approved drug product in the Drugs@FDA database
9. FDA, bulk drug substances used in compounding under section 503A: AOD-9604 is not on FDA's list of bulk drug substances permitted for 503A pharmacy compounding
10. eCFR, 21 CFR 216.24, the 503B Bulks List: AOD-9604 is not included on the 503B outsourcing facility bulk drug substances list
11. Cornell Law, 21 U.S.C. 353a, pharmacy compounding: Federal statute governing which bulk substances pharmacies may legally use in compounded drug preparations
12. eCFR, 21 CFR 201.128, meaning of intended uses: FDA's intended-use regulation determines how labeling and marketing claims affect a substance's regulatory status as a drug
13. PubMed, Drug Testing and Analysis (2013), PMID 24124033: AOD-9604 does not influence the WADA hGH isoform immunoassay used in anti-doping testing
14. PubMed, Journal of Separation Science (2016), PMID 26578461: Analytical method using direct urine injection, liquid chromatography, and ion mobility mass spectrometry to screen for peptides under 2 kDa
15. PubMed, Journal of Pharmaceutical and Biomedical Analysis (2014), PMID 24906629: Analytical approaches developed for detecting emerging non-approved therapeutics including peptide fragments in doping controls
16. PubMed, Expert Review of Proteomics (2014), PMID 25382550: Review of methods for detecting peptidic drugs, drug candidates and analogs in sports doping controls